ArticleCancer research2024

A Dual-Payload Antibody-Drug Conjugate Targeting CD276/B7-H3 Elicits Cytotoxicity and Immune Activation in Triple-Negative Breast Cancer.

Zhuoxin Zora Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.